Abbott, a health care products conglomerate ... approved by the U.S. Food and Drug Administration (FDA). Yet unlike baby formula, the toddler milk products are not regulated by the FDA and are ...

The lawsuit accuses Abbott of creating products called “transition formulas,” “follow-on formulas,” “weaning formulas” and “toddler milks” to boost earnings as infant formula sales ...

Abbott, a health care products conglomerate ... approved by the U.S. Food and Drug Administration (FDA). Yet unlike baby formula, the toddler milk products are not regulated by the FDA and are ...

Danielle and Andrew West spent their first month as parents praying their child would live. Their son Owen, born six weeks early in November 2015, developed necrotizing enterocolitis a few days ...

Abbott initiated a recall as part of a larger voluntary action covering Similac, Alimentum, and EleCare. The dominant player in the U.S. infant formula market, Abbott controls about 40% of the market ...

In this article, we are going to take a look at where Abbott Laboratories (NYSE:ABT) stands against the other stocks on Jim Cramer's radar. Jim Cramer, host of Mad Money, recently emphasized the ...

The toxic baby food crisis is not just a failure in public health. It is a defining moral challenge for an industry entrusted ...

A bipartisan effort in the U.S. Senate seeks to improve the safety of infant formula. Introduced by Sen. John Hoeven, R-ND, and Sen. Gary Peters, D-MI, ...

Abbott is, of course ... can’t or don’t want to breastfeed for that length of time. Either way, infant formula is not recommended after age one. Murphy says that while there are benefits ...

I think Abbott will win these baby formula cases. Yet, who wants that overhang, right? Certainly not Wall Street. So what does this stock do? It languishes. Who knows how quickly things can change ...